Paul Schimmel Net Worth & Insider Trades
Paul Schimmel - Director, Atyr Pharma Inc
What is Paul Schimmel's Net Worth?
The current estimated net worth of Atyr Pharma Inc's Director, Paul Schimmel, is estimated to be about $190.5M . Paul Schimmel owns about 792,166 units of Atyr Pharma Inc common stock. In the last 7 years at Atyr Pharma Inc, Paul Schimmel has sold an estimated value of $30.74K worth.
What is Paul Schimmel's Past Insider Trading?
Paul Schimmel's largest purchase order was 500,000 units , worth over $2M on September 22, 2021. Paul Schimmel's largest sale order was 8,447 units , worth over $30.74K on May 22, 2020. In total, Paul Schimmel has made about 30 transactions over 7 years of their time at Atyr Pharma Inc. Paul Schimmel usually trades in April, with the busiest year in 2016.
PAUL SCHIMMEL
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Paul Schimmel's' Mailing Address?
- Mailing address is 88 Sidney St Cambridge MA 02139 MA
Atyr Pharma Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sanjay S. Shukla, M.D., M.S. | 2020 | $470,250 | $223,369 | $381,811 | $223,369 | $8,427 | $1,083,857 |
| Sanjay S. Shukla, M.D., M.S. | 2019 | $450,000 | $95,625 | $82,400 | $95,625 | $10,076 | $663,961 |
| Jill M. Broadfoot | 2020 | $365,750 | $138,985 | $182,671 | $138,985 | $11,374 | $698,780 |
| Jill M. Broadfoot | 2019 | $350,000 | $59,500 | $20,600 | $59,500 | $11,594 | $454,624 |
| Nancy E. Denyes | 2020 | $350,075 | $116,400 | $148,121 | $116,400 | $10,661 | $625,257 |
| Nancy E. Denyes | 2019 | $335,000 | $49,831 | $51,500 | $49,831 | $12,932 | $449,263 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1339970/000156459021014935/life-def14a_20210428.htm
What are Atyr Pharma Inc's Past Insider Trades?
Atyr Pharma Inc's most recent insider trade came on February 6, 2023 by Marie Jill Broadfoot who sold 1,566 units worth $3.7K . In the last 8 years, insiders at Atyr Pharma Inc have sold an estimated value of $3.13M and bought an estimated value of $16.51M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Paul Schimmel, Director, Sanjay Shukla, President and CEO, and John Mendlein, Director .
aTYR PHARMA INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||